Chronic myeloid leukemia (CML) is a type of blood cancer. The number of people with CML who are living well is growing. This is due to new treatments. Six new CML drugs have been approved since 2024. Other new treatments are being studied in clinical trials. Progress toward a cure is under way.
Still, these drugs don't always work, and CML can become resistant to TKIs over time. Scientists continue to look for new drugs to treat CML, especially CML that no longer responds to TKIs. In some people, CML cells develop a change in the BCR-ABL oncogene known as a T315I mutation, which makes them resistant to many of the TKI drugs used today
Professor Helgason is researching a new way to treat CML by combining drug treatments with other treatment methods.
CML; Leukemia, Chronic Granulocytic. Chronic Myelogenous Subscribe to our newsletter for the latest medication news, new drug approvals and FDA alerts.
Fall 2024 : New Generation of Drugs for CML New Generation of Drugs for CML Hagop Kantarjian, M.D, presented encouraging results of a study with dasatinib for patients with chronic myeloid leukemia.
The FDA has cleared an investigational new drug application for TERN-701 as a treatment for patients with chronic myeloid leukemia (CML).
Still, these drugs don't always work, and CML can become resistant to TKIs over time. Scientists continue to look for new drugs to treat CML, especially CML that no longer responds to TKIs. In some people, CML cells develop a change in the BCR-ABL oncogene known as a T315I mutation, which makes them resistant to many of the TKI drugs used today
chronic myeloid leukemia (CML). Clinical trials have helped develop new drugs, while also establishing new uses for accepted drugs.
CML Gold Standard SOHO 2024 For Treatment Value, Imatinib Remains the CML Gold Standard New Trials ESC 2024 Time Antihypertensives Taken Doesn't Matter: New
Comments